Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.
Malignant hyperthermia (MH) in man is an autosomal dominant disorder of skeletal muscle Ca(2+)-regulation. During anesthesia in predisposed individuals, it is triggered by volatile anesthetics and depolarizing muscle relaxants. In >50% of the families, MH susceptibility is linked to the gene encoding the skeletal muscle ryanodine receptor (RYR1), the calcium release channel of the sarcoplasmic reticulum, on chromosome 19q12-13.2. To date, 21 RYR1 mutations have been identified in a number of pedigrees. Four of them are also associated with central core disease (CCD), a congenital myopathy. Screening for these 21 mutations in 105 MH families including 10 CCD families phenotyped by the in vitro contracture test (IVCT) according to the European protocol revealed the following approximate distribution: 9% Arg-614-Cys, 1% Arg-614-Leu, 1% Arg-2163-Cys, 1% Val-2168-Met, 3% Thr-2206-Met and 7% Gly-2434-Arg. In one CCD family, the disease was caused by a recently reported MH mutation, Arg-2454-His. Two novel mutations, Thr-2206-Arg and Arg-2454-Cys were detected, each in a single pedigree. In the 109 individuals of the 25 families with RYR1 mutations cosegregation between genetic result and IVCT was almost perfect, only three genotypes were discordant with the IVCT phenotypes, suggesting a true sensitivity of 98.5% and a specificity of minimally 81.8% for this test. Screening of the transmembraneous region of RYR1 did not yield a new mutation confirming the cytosolic portion of the protein to be of main functional importance for disease pathogenesis.
Brandt
A
A
Department of Applied Physiology, University of Ulm, Albert-Einstein-Allee, Germany.
Schleithoff
L
L
Jurkat-Rott
K
K
Klingler
W
W
Baur
C
C
Lehmann-Horn
F
F
D000328:Adult; D019943:Amino Acid Substitution; D002648:Child; D003062:Codon / Q000235:genetics; D004252:DNA Mutational Analysis; D017809:Fatal Outcome; D005260:Female; D005787:Gene Frequency; D008040:Genetic Linkage; D005820:Genetic Testing; D005838:Genotype; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000453:epidemiology / Q000235:genetics*; D009119:Muscle Contraction; D009124:Muscle Proteins / Q000737:chemistry / Q000235:genetics*; D020512:Myopathy, Central Core / Q000235:genetics*; D010375:Pedigree; D010641:Phenotype; D017354:Point Mutation; D017434:Protein Structure, Tertiary / Q000235:genetics; D019837:Ryanodine Receptor Calcium Release Channel / Q000737:chemistry / Q000235:genetics*; D012680:Sensitivity and Specificity
D003062:Codon; D009124:Muscle Proteins; D019837:Ryanodine Receptor Calcium Release Channel